Sharon Cox, MD
Internal Medicine · Columbia, MDNPI 1487904702
Payments from drug & device makers
Across 129 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$276
- Lilly USA, LLC$269
- Novo Nordisk$247
- Merck$187
- Abbott$166
- Astellas Pharma US Inc$136
- plus $963 from 28 others
What the payments were for
- Food & beverage$2,23299%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $276 |
| Lilly USA, LLC | 16 | $269 |
| Novo Nordisk | 13 | $247 |
| Merck | 10 | $187 |
| Abbott | 9 | $166 |
| Astellas Pharma US Inc | 7 | $136 |
| Boehringer Ingelheim | 5 | $101 |
| AstraZeneca(2 entities) | 6 | $93 |
| GSK | 4 | $75 |
| Exact Sciences | 3 | $69 |
| Amarin Pharma, Inc. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Corcept Therapeutics | 2 | $45 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Philips North America LLC | 2 | $39 |
| Amgen | 2 | $35 |
| Boston Scientific | 1 | $29 |
| Redhill Biopharma Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Bausch Health US, LLC | 2 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| AbbVie | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Tolmar, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
| Smith+Nephew | 1 | $12 |
How this compares
$2,243 in reported general payments places this provider in the 80th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $20,579 |
| XareltoRivaroxaban | 16 | $18,179 |
| EliquisApixaban | 12 | $11,992 |
| JardianceEmpagliflozin | 11 | $11,577 |
| Atorvastatin Calcium | 137 | $1,769 |
| Rosuvastatin Calcium | 63 | $1,576 |
| SynthroidLevothyroxine Sodium | 13 | $1,150 |
| Amlodipine Besylate | 122 | $1,123 |
| Losartan Potassium | 64 | $816 |
| Lisinopril | 89 | $774 |
| Metoprolol Succinate | 46 | $702 |
| Alendronate Sodium | 35 | $663 |
| Levothyroxine Sodium | 59 | $572 |
| Hydralazine Hcl | 25 | $572 |
| Metformin Hcl ErMetformin Hcl | 25 | $562 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $247 | $20,57918 claims |
| Johnson & JohnsonXarelto | $25 | $18,17916 claims |
| PfizerEliquis | $276 | $11,99212 claims |
| Boehringer IngelheimJardiance | $101 | $11,57711 claims |
| AbbVieSynthroid | $19 | $1,15013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Columbia
- Mark CorriereColumbia$402K
- Saba SheikhColumbia$342K
- William SawayColumbia$295K
- Shishir KhetanRockville$52.1M
- Steven GellerElkridge$15.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.